2-(3,3-Dimethyl-3,4-dihydro-isoquinolin-1-ylamino)-propionic acid, 95.0%, 1g

2-P-TOLYLTHIAZOLE-4-CARBALDEHYDE, 95.0%, 250mg

3-BROMO-6-(TRIFLUOROMETHYL)IMIDAZO[1,2-A]PYRIDINE, 97.0%, 5g

4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)indolin-2-one, 95.0%, 100mg

1-Naphthylacetic acid, min. 99%, pa, 100 g, plastic packaging.

(6-(Methylsulfonyl)pyridin-3-yl)methanamine dihydrochloride, 98%, 100mg

(S)-3-Oxo-N-(2-oxotetrahydrofuran-3-yl)hexanamide, 95%, 50mg

2-Chloro-6-phenylpyridine, 95.0%, 250mg

2-(3-(4-Chlorophenyl)pyrrolidin-3-yl)ethanol, 95.0%, 250mg

1-(2-Cyanoethyl)-2-ethyl-4-methylimidazole (contains 5-methyl isomer)>70.0%(GC)25g

2-Ureidosuccinic acid, 95.0%, 25g

(R)-2-(tert-Butoxycarbonyl)-1,2,3,4-tetrahydroisoquinoline-1-carboxylic acid, 95.0%, 250mg

{[(2R)-1,4-Dioxan-2-yl]methyl}(methyl)amine, 98%, 250mg